Andrew D. Dickinson
CIK: 0001310204
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GILEAD SCIENCES, INC.
Discretionary Trading P&L
Holdings
Transaction History (72 total)
- Oct 15, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3K shares at avg. $156.22$469K - Sep 15, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3K shares at avg. $145.29$436K - Sep 10, 2026GILD
GILEAD SCIENCES, INC.
Tax Payment(F)Direct1.3K shares at avg. $144.81$195K - Sep 10, 2026GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct2.8K shares- - Aug 17, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3K shares at avg. $138.36$415K - Jul 15, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3K shares at avg. $129.93$390K - Jun 15, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3K shares at avg. $125.40$376K - Jun 10, 2026GILD
GILEAD SCIENCES, INC.
Tax Payment(F)Direct1.3K shares at avg. $121.48$163K - Jun 10, 2026GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct2.8K shares- - May 15, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3K shares at avg. $132.27$397K - Apr 15, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3K shares at avg. $140.96$423K - Mar 16, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3K shares at avg. $144.23$433K - Mar 10, 2026GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct6.5K shares- - Mar 10, 2026GILD
GILEAD SCIENCES, INC.
Tax Payment(F)Direct3.1K shares at avg. $148.56$468K - Mar 10, 2026GILD
GILEAD SCIENCES, INC.
Award(A)DirectNon-qualified Stock Option (Right to Buy)
35.9K shares- - Mar 10, 2026GILD
GILEAD SCIENCES, INC.
Award(A)DirectRestricted Stock Unit
9.6K shares- - Feb 27, 2026GILD
GILEAD SCIENCES, INC.
Award(A)Direct11.1K shares- - Feb 17, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3K shares at avg. $154.43$463K - Feb 3, 2026GILD
GILEAD SCIENCES, INC.
Award(A)Direct44.9K shares- - Feb 3, 2026GILD
GILEAD SCIENCES, INC.
Tax Payment(F)Direct24.8K shares at avg. $143.28$3.6M - Jan 15, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3K shares at avg. $124.31$373K - Dec 15, 2025GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3K shares at avg. $122.00$366K - Dec 10, 2025GILD
GILEAD SCIENCES, INC.
Tax Payment(F)Direct1.7K shares at avg. $121.34$212K - Dec 10, 2025GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct3.7K shares- - Nov 17, 2025GILD
GILEAD SCIENCES, INC.
Sale(S)Direct2.5K shares at avg. $125.23$313K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,000 | $156.22 | $468,660 | Direct |
| Sep 15, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,000 | $145.29 | $435,870 | Direct |
| Sep 10, 2026 | GILD GILEAD SCIENCES, INC. | Tax Payment(F) | 1,347 | $144.81 | $195,059 | Direct |
| Sep 10, 2026 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 2,797 | - | $0 | Direct |
| Aug 17, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,000 | $138.36 | $415,080 | Direct |
| Jul 15, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,000 | $129.93 | $389,777 | Direct |
| Jun 15, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,000 | $125.40 | $376,200 | Direct |
| Jun 10, 2026 | GILD GILEAD SCIENCES, INC. | Tax Payment(F) | 1,341 | $121.48 | $162,905 | Direct |
| Jun 10, 2026 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 2,796 | - | $0 | Direct |
| May 15, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,000 | $132.27 | $396,810 | Direct |
| Apr 15, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,000 | $140.96 | $422,880 | Direct |
| Mar 16, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,000 | $144.23 | $432,690 | Direct |
| Mar 10, 2026 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 6,469 | - | $0 | Direct |
| Mar 10, 2026 | GILD GILEAD SCIENCES, INC. | Tax Payment(F) | 3,147 | $148.56 | $467,518 | Direct |
| Mar 10, 2026 | GILD GILEAD SCIENCES, INC. | Award(A) Non-qualified Stock Option (Right to Buy) | 35,880 | - | - | Direct |
| Mar 10, 2026 | GILD GILEAD SCIENCES, INC. | Award(A) Restricted Stock Unit | 9,590 | - | - | Direct |
| Feb 27, 2026 | GILD GILEAD SCIENCES, INC. | Award(A) | 11,090 | - | $0 | Direct |
| Feb 17, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,000 | $154.43 | $463,290 | Direct |
| Feb 3, 2026 | GILD GILEAD SCIENCES, INC. | Award(A) | 44,867 | - | $0 | Direct |
| Feb 3, 2026 | GILD GILEAD SCIENCES, INC. | Tax Payment(F) | 24,802 | $143.28 | $3,553,631 | Direct |
| Jan 15, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,000 | $124.31 | $372,930 | Direct |
| Dec 15, 2025 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,000 | $122.00 | $366,000 | Direct |
| Dec 10, 2025 | GILD GILEAD SCIENCES, INC. | Tax Payment(F) | 1,745 | $121.34 | $211,738 | Direct |
| Dec 10, 2025 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 3,693 | - | - | Direct |
| Nov 17, 2025 | GILD GILEAD SCIENCES, INC. | Sale(S) | 2,500 | $125.23 | $313,075 | Direct |
1-25 of 72 transactions
About Dickinson Andrew D
Dickinson Andrew D (SEC CIK 0001310204) files insider reports with the SEC as Chief Financial Officer of GILEAD SCIENCES, INC. (GILD).
Signal8 holds 38 ownership filings by Dickinson Andrew D, all Form 4s, filed between Sep 11, 2024 and Oct 16, 2026. Those filings report 72 transactions, from Sep 10, 2024 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dickinson Andrew D's filings is in FOSTER CITY, CA.
Recent filings by Dickinson Andrew D
- Oct 15, 2026: Open-market sale of GILD shares (Form 4, code S).
- Sep 15, 2026: Open-market sale of GILD shares (Form 4, code S).
- Sep 10, 2026: Tax withholding of GILD shares (Form 4, code F).
- Sep 10, 2026: Option exercise of GILD shares (Form 4, code M).
- Aug 17, 2026: Open-market sale of GILD shares (Form 4, code S).
Other insiders filing for GILEAD SCIENCES, INC. (GILD)
- O'Day Daniel Patrick, Chairman & CEO
- Mercier Johanna, Chief Comm & Corp Aff Officer
- Burkhart Erin, SVP, Controllership
- Berger Dietmar, Chief Medical Officer
- Cain Wettan Keeley M, EVP Gen Counsel, Legal & Comp
- WELTERS ANTHONY, Director